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Valorisation 
In addition to the scientific relevance of the studies performed in this thesis, it is 
important to also discuss the relevance besides science, for instance the relevance in 
clinical settings, but also the societal and economical relevance. The valorisation of the 
acquired knowledge about comorbidities of overweight and obesity in children, with a 
special focus on non-alcoholic fatty liver disease (NAFLD), and the effect of 
multidisciplinary lifestyle intervention on BMI z-score and comorbidities, are further 
elaborated in this chapter.  
 
An unhealthy lifestyle and obesity are important causes of morbidity and mortality 
worldwide. As we have shown in this thesis, and was previously also shown by others (1, 
2), the development of comorbidities is already seen at a young age. In addition to 
physical health consequences, children with overweight and obesity are more likely to 
suffer from psychological problems, like depression, low self-esteem and decreased 
quality of life (3). Moreover, children with overweight or obesity are likely to become 
adults with obesity and the associated comorbidities are also likely to track into adulthood 
(4). Finally, in addition to the effects of long-term obesity on the health of the individual, 
there is also a substantial economical and societal burden.  
A previous German study has estimated that the expected excess lifetime healthcare costs 
were higher (3.7 and 5 times higher, respectively in men and women) in adults that were 
overweight or obese as a child compared to adults that had a normal weight as a child (5). 
Another previous German study has estimated that a BMI higher than 40 kg/m
2 
in adults is 
associated with healthcare costs twice as high as in adults with a normal weight. 
Additional costs for society, mainly due to reduced work productivity, sick leave and long-
term incapacity was also twice as high in these adults with morbid obesity (6).  
 
The fact that obesity and the associated diseases like diabetes, cardiovascular disease and 
NAFLD can have serious consequences on the health of the individual, but also constitutes 
an economic burden for society, underlines the need for prevention and effective 
interventions. The results of one of the studies in this dissertation have shown that there 
was a clinically relevant decrease in BMI z-score and health outcomes improve after one 
year of on-going, family-based, multidisciplinary lifestyle intervention in children with 
obesity at the Centre for Overweight Adolescent and Children’s Healthcare (COACH). This 
study also showed that these positive effects, on both BMI z-score and health outcomes, 
are more pronounced in younger children. At this time, a cost-benefit analysis of the 
COACH program has not yet been performed, however it is expected that the 
aforementioned approach contributes to reduced healthcare costs of the treatment of 
childhood obesity. A recent societal cost-benefit analysis of a two-year multidisciplinary 
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lifestyle intervention in children with overweight and obesity (in Arnhem, the 
Netherlands) estimated that the economic benefits of such an intervention are 4-7 higher 
than the costs (7). In this study, the lifetime economic benefit of lifestyle intervention in 
children was estimated to be between 11384 and 19120 euros per individual, mainly due 
to decreased current and future healthcare costs and an improved quality of life due to a 
decreased disease burden.  
 
In current society, living a healthy lifestyle and losing weight can be a difficult goal to 
achieve, since unhealthy products and services are easily available. Creating a society in 
which healthy options are accessible and affordable for everyone, requires combined 
efforts from stakeholders at multiple levels, like different health care professionals (for 
instance physicians, dieticians and psychologists), schools, sports clubs, supermarkets and 
(local) governments.  
In the COACH lifestyle intervention, an interdisciplinary team of health care providers 
works together with various stakeholders to provide a tailor-made intervention for each 
child and their family. The aim is to achieve and maintain a healthy lifestyle by making 
small, step-by-step lifestyle changes that can be maintained throughout a long period of 
time. In order to achieve this, children and their families receive individual guidance, 
focusing on personalized lifestyle improvements. Of course, intervention programs could 
be considered costly, because long-term care is provided. In order to limit the costs of this 
intervention, the intervention plan is tailored to the needs of each child and their family, 
rather than providing the same plan for all children. In this approach, focus points that are 
identified before the intervention (and might be adjusted during the intervention) are 
prioritized together with the family, in order to provide the appropriate guidance at 
different moments throughout the intervention. Moreover, during the past decade, the 
COACH program has evolved into an elaborate collaboration with different local 
stakeholders, such as youth health care, dieticians, a family coach, but also the local 
municipality, fruit and vegetable farmers and supermarkets. Together with these partners, 
children are stimulated to lead a healthier lifestyle by participating in sports and healthy 
food-related activities on a regular basis, in addition to the individual guidance by health 
care providers. Working together with multiple societal partners that are also motivated in 
helping to create a healthier living environment for children, contributes to the 
commitment and success of the intervention.  
 
Based on the experiences of COACH and seven other regional lifestyle interventions in the 
Netherlands, aimed at guiding children with obesity and their families, a national 
approach for the care for these children was developed recently (‘landelijk model 
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ketenaanpak voor kinderen met overgewicht en obesitas’). This model provides a basis 
and step-wise approach for health care providers and societal partners that aim to 
accomplish a local network collaboration to provide care for children with overweight and 
obesity. With this national model, the same approach can be expanded to other regions, 
but also to a broader target group (i.e. children across the entire overweight – morbid 
obesity spectrum). Expanding the lifestyle interventions that are currently already 
available for children is necessary to ensure that all children and their families can receive 
help in achieving and maintaining a healthy lifestyle. Prevention of (increasing) overweight 
and obesity and the associated health consequences will have a positive effect on the 
physical and psychosocial health of the individual, but will also help in decreasing the 
societal burden of obesity (e.g. by decreasing costs and increasing work productivity).    
 
In this dissertation we have not only studied the comorbidities of childhood obesity in 
general, but also studied non-alcoholic fatty liver disease specifically. The prevalence of 
NAFLD has strongly increased the past decades, alongside the obesity epidemic. As was 
discussed in the previous chapters of this dissertation, hepatic steatosis and 
steatohepatitis (NASH) will progress to liver cirrhosis and liver failure in a subgroup of 
patients, possible necessitating a liver transplantation. Also, NAFLD patients have an 
increased risk of developing hepatocellular carcinoma, illustrating that the disease can 
have severe consequences for the health of the individual. Finally, NAFLD has been 
associated with an increased risk for developing cardiovascular disease and diabetes type 
II. These findings underline the importance of early recognition of NAFLD patients.  
 
A recent study showed that between 2006 and 2016, the number of NAFLD-related liver 
transplantations increased by 170% in the United States, making it the second leading 
cause of liver transplantation (8). Currently, weight loss through lifestyle improvements is 
the recommended treatment for children with NAFLD. Therefore, lifestyle interventions, 
such as the COACH program, can contribute to decreasing disease severity and preventing 
progression to severe disease states that might require a liver transplant. However, since 
weight loss is currently the only proven treatment for NAFLD in children, there is an 
urgent need for other treatment options to prevent progression to severe stages of the 
disease, especially in patients that experience difficulties in achieving and maintaining 
weight loss.  
 
NAFLD is often asymptomatic and most patients do not have specific symptoms until they 
have progressed to the severe stages of the disease spectrum. Currently, the gold 
standard for diagnosing and staging non-alcoholic fatty liver disease is a liver biopsy. Since 
197
this is an invasive procedure with a small risk of severe complications, liver biopsies are 
not suitable for screening the large number of people that are at-risk for developing 
NAFLD. As mentioned previously in this dissertation, other diagnostic modalities are less 
suitable for screening purposes or have limited sensitivity for staging NAFLD. Therefore, an 
increased insight in the children that are at risk for (progressive) NAFLD can help in an 
early clinical recognition of these children, in which prevention of further weight gain and 
metabolic disturbances is very important. In the studies in this dissertation, we have 
evaluated parameters that are associated with the different stages of NAFLD in children 
with overweight and obesity. An increased insight into the factors associated with NAFLD 
development and progression can also help in the development of new treatment 
modalities.  
In addition to affecting the individual, the health consequences associated with NAFLD 
also have significant economic consequences. It was recently estimated that the direct 
annual economic burden of NAFLD in 4 European countries (Germany, France, Italy and 
the United Kingdom) was 35 billion euros. When combined with the societal costs of the 
loss of quality adjusted life years due to NAFLD and its complications, the annual economic 
burden was estimated to be 228 billion euros. Costs due to a loss in work productivity 
were not taken into account in this estimation. Also, this study did not investigate whether 
the economic burden was dependent or independent of obesity (9). It is to be expected 
that early recognition of patients that have developed NAFLD, increased insight in the risk 
factors for (fast) progressive disease and new treatment options contribute to a decreased 
burden on the healthcare system, including liver transplantations, and a decreased 
societal economic burden.  
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